Ginkgo Bioworks Holdings Stock (NYSE: DNA)

Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Stuttgart,,Germany,-,07-19-2023:,Person,Holding,Smartphone,With,Logo,Of

Biotech

Government

News

Health Care

Markets

Tech

ABSI

NOTV

NVDA

RXRX

SDGR

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA&#39;s Decision To End Animal Testing

Stuttgart,,Germany,-,07-01-2023:,Person,Holding,Cellphone,With,Logo,Of

Intraday Update

Movers

Trading Ideas

AMRN

CBLL

CERT

FAST

NMAX

ZLAB

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday

movers image

Pre-Market Outlook

ACEL

CART

CDNA

FLYW

LBTYK

LMND

NAMS

SGRY

ZETA

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings Inc

Metaverse Dualchain Network Architecture

DeNA Co Ltd

DNAPRINT GENOMICS INC by DNAPrint Genomics, Inc.

DNA Print Genomics Inc

DNA Brands Inc

Press Releases

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Earnings

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom

Contracts

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Commodities

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

ADIA

FATE

PLUR

TWST

Alto Ingredients

Ashland

ASP Isotopes

Aspen Aerogels

Avient

Bon Natural Life Limited - Class A Ordinary Shares

Bon Natural Life

Ecovyst

Flexible Solutions International Inc. Common Stock (CDA)

Flexible Solutions Intl

Flotek Industries

H.B. Fuller

Innospec

Quaker Houghton

Minerals Technologies

Ingevity

Northern Technologies International Corporation - Common Stock

Northern Technologies

Perimeter Solutions

Rayonier Advanced Materials Inc. Common Stock

Rayonier Adv Materials

Stepan

Solesence

Valhi

TD Cowen

BTIG

Goldman Sachs

Morgan Stanley

Genentech

Comments

Ginkgo Bioworks Holdings

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell